ARCHIVES

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons

June 1, 1984

Foreeman, Brinker, Jako Appointed To Cancer Panel

April 19, 1991

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

House Overrides Veto Of Authorization Bill As GOP Members Join Democrats In Assailing Reagan Action

November 15, 1985

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002